Showing results (41-50 of 50) with videos related to
Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 50 results.
Current Oncology (Toronto, Ont.)|September 26, 2025
De-Escalation of Treatment in Women Aged ≥80 Years with Breast Cancer: A Retrospective Analysis from Two Breast CentersGianmarco Piccolino, Giulia Cardelli, Francesca Arienzo, et al.Breast (Edinburgh, Scotland)|November 15, 2022
PARP-inhibitors for BRCA1/2-related advanced HER2-negative breast cancer: A meta-analysis and GRADE recommendations by the Italian Association of Medical OncologyFederica Miglietta, Michela Cinquini, Maria Vittoria Dieci, et al.BMC Health Services Research|June 1, 2022
Integrating mammography screening programmes into specialist breast centres in Italy: insights from a national survey of Senonetwork breast centresSilvia Deandrea, Francesca Ferrè, Rosanna D'Antona, et al.Current Oncology (Toronto, Ont.)|September 27, 2023
Presence and Role of Associations of Cancer Patients and Volunteers in Specialist Breast Centres: An Italian National Survey of Breast Centres Associated with SenonetworkRosanna D'Antona, Silvia Deandrea, Elisabetta Sestini, et al.International Journal of Radiation Oncology, Biology, Physics|October 25, 2020
Long-Term Outcomes of Once-Daily Accelerated Partial-Breast Irradiation With Tomotherapy: Results of a Phase 2 TrialUgo de Paula, Rolando Maria D'Angelillo, Angela Damiana Andrulli, et al.European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|January 13, 2024
Is routine axillary lymph node dissection needed to tailor systemic treatments for breast cancer patients in the era of molecular oncology? A position paper of the Italian National Association of Breast Surgeons (ANISC)Nicola Rocco, Matteo Ghilli, Annalisa Curcio, et al.Cancer Treatment Reviews|August 29, 2024
Parp-inhibitors in the therapeutic landscape of breast cancer patients with BRCA1 and BRCA2 pathogenic germline variants: An Italian consensus paper and critical reviewAlberto Zambelli, Laura Cortesi, Mariangela Gaudio, et al.Tumori|September 15, 2025
The use of bone-modifying agents in early breast cancer: AIOM Guidelines update and perspectivesAlberto Zambelli, Riccardo Gerosa, Michela Cinquini, et al.Breast Cancer Research and Treatment|November 10, 2021
Safety of autologous fat grafting in breast cancer: a multicenter Italian study among 17 senonetwork breast units autologous fat grafting safety: a multicenter Italian retrospective studyMarco Klinger, Agnese Losurdo, Andrea V E Lisa, et al.The Breast Journal|May 19, 2023
The Effect of Adjuvant Radiotherapy on One- and Two-Stage Prosthetic Breast Reconstruction and on Autologous Reconstruction: A Multicenter Italian Study among 18 Senonetwork Breast CentresAndrea Vittorio Emanuele Lisa, Marzia Salgarello, Alessandra Huscher, et al.Pageof 5